Gold nanoparticles as carriers for a syntheticStreptococcus pneumoniaetype 14 conjugate vaccine

Both Th1 and Th17 Are Immunopathogenic but Differ in Other Key Biological Activities

(2014) C. A. Cox et al.   JOURNAL OF IMMUNOLOGY

What do the next 100 years hold for pneumococcal vaccination?

(2010) Ger T Rijkers et al.   Expert Review of Vaccines

Synthesis of Multivalent Tuberculosis andLeishmania-Associated Capping Carbohydrates Reveals Structure-Dependent Responses Allowing Immune Evasion

(2010) Eun-Ho Song et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Synthesis of a Single-Moleculel-Rhamnose-Containing Three-Component Vaccine and Evaluation of Antigenicity in the Presence of Anti-l-Rhamnose Antibodies

(2010) Sourav Sarkar et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Glyconanoparticles: multifunctional nanomaterials for biomedical applications

(2010) Isabel García et al.   Nanomedicine

Carbohydrate vaccines: developing sweet solutions to sticky situations?

(2010) Rena D. Astronomo et al.   NATURE REVIEWS DRUG DISCOVERY

Nanoparticle Delivery Systems in Cancer Vaccines

(2010) Yogita Krishnamachari et al.   PHARMACEUTICAL RESEARCH

A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies

(2010) Laura C. Kennedy et al.   Small

Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates

(2010) Dodi Safari et al.   VACCINE

Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity

(2009) Elodie Boisselier et al.   CHEMICAL SOCIETY REVIEWS

GoldManno-Glyconanoparticles: Multivalent Systems to Block HIV-1 gp120 Binding to the Lectin DC-SIGN

(2009) Olga Martínez-Ávila et al.   CHEMISTRY-A EUROPEAN JOURNAL

Carbohydrates: A Frontier in Medicinal Chemistry

(2009) Pierre Stallforth et al.   JOURNAL OF MEDICINAL CHEMISTRY

Rational design and immunogenicity of liposome-based diepitope constructs: Application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen

(2009) Fatouma Said Hassane et al.   VACCINE

Identification of the Smallest Structure Capable of Evoking Opsonophagocytic Antibodies against Streptococcus pneumoniae Type 14

(2008) D. Safari et al.   INFECTION AND IMMUNITY

Peptides conjugated to gold nanoparticles induce macrophage activation

(2008) Neus G. Bastús et al.   MOLECULAR IMMUNOLOGY

Design opportunities for actively targeted nanoparticle vaccines

(2008) Tarek M Fahmy et al.   Nanomedicine

Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands

(2008) Paula M Castillo et al.   Nanomedicine

An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

(2008) J. G. Joyce et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN

(2008) S.-K. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization

(2008) Ying-Jie Lu et al.   PLoS Pathogens